Based on these results, we hypothesized that targeted demethylation of SLC5A7 could stabilize p53 and cause p53-mediated inhibition of the cancer cell cycle and enhancement of apoptosis [40], which would be a targeted therapeutic strategy for CRC. This evidence concerns the gene TP53 and colorectal carcinoma.